1. Akt inhibitor MK2206 selectively targets CLL B‐cell receptor induced cytokines, mobilizes lymphocytes and synergizes with bendamustine to induce CLL apoptosis. (20th September 2013) Authors: Ding, Wei; Shanafelt, Tait D.; Lesnick, Connie E.; Erlichman, Charles; Leis, Jose F.; Secreto, Charla; Sassoon, Traci R.; Call, Timothy G.; Bowen, Deborah A.; Conte, Michael; Kumar, Shaji; Kay, Neil E. Journal: British journal of haematology Issue: Volume 164:Number 1(2014:Jan.) Page Start: 146 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Akt inhibitor MK‐2206 in combination with bendamustine and rituximab in relapsed or refractory chronic lymphocytic leukemia: Results from the N1087 alliance study. Issue 8 (1st June 2017) Authors: Larsen, Jeremy T.; Shanafelt, Tait D.; Leis, Jose F.; LaPlant, Betsy; Call, Tim; Pettinger, Adam; Hanson, Curtis; Erlichman, Charles; Habermann, Thomas Matthew; Reeder, Craig; Nikcevich, Daniel; Bowen, Deborah; Conte, Michael; Boysen, Justin; Secreto, Charla; Lesnick, Connie; Tschumper, Renee; Je... Journal: American journal of hematology Issue: Volume 92:Issue 8(2017:Aug.) Page Start: 759 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Tris (dibenzylideneacetone) dipalladium: a small-molecule palladium complex is effective in inducing apoptosis in chronic lymphocytic leukemia B-cells. Issue 10 (2nd October 2016) Authors: Kay, Neil E.; Sassoon, Traci; Secreto, Charla; Sinha, Sutapa; Shanafelt, Tait D.; Ghosh, Asish K.; Arbiser, Jack L. Journal: Leukemia & lymphoma Issue: Volume 57:Issue 10(2016:Oct.) Page Start: 2409 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗